What’s trending on NP Privacy Partner



October 26, 2017

NP Privacy Partner

Author(s): Valerie Breslin Montague, Steven M. Maffucci, Eric M. Ferrante, John Ruskusky, Richard H. Tilghman IV, Brian V. Alcala

OCR issues guidance summarizing permissible health information disclosures, FBI unable to access nearly 7,000 devices over the last year, Congress is helping small businesses understand and protect against cybersecurity risks and what you need to know about the Illinois Biometric Information Privacy Act. Here’s what’s trending in data privacy and cybersecurity.

Healthcare and HIPAA

OCR issues guidance summarizing permissible health information disclosures to friends and family

Hospitals, physicians and other HIPAA covered entities may disclose certain PHI to those involved in a patient’s care.—Valerie Breslin Montague

Read More

Cybersecurity

FBI unable to access nearly 7,000 devices over the last year

Debates continue about the competing privacy and law enforcement concerns in seeking to unlock seized devices in criminal investigations.—Steven M. Maffucci

Read More

Congress is working to help small businesses understand and deal with cybersecurity risks

Last week, the United States House of Representatives unanimously passed the National Institute of Standards and Technology (NIST) Small Business Cybersecurity Act, a bill that would require the NIST to issue cybersecurity guidelines specific to the needs of small businesses.—Eric M. Ferrante

Read More

Privacy Litigation & Class Action

What you need to know about the Illinois Biometric Information Privacy Act

The cases interpreting Illinois' BIPA on these issues are mixed, however, and the law is currently unsettled.—John Ruskusky, Richard H. Tilghman IV, Brian V. Alcala

Read More

The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

Back to top